INFORMATION STATEMENT

Company

TherapeuticsMD, Inc.

Filed

December 4, 2012

Accession Number

0001387131-12-003943

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →